1449 / 1544
Pooled estimated OS at 1 and 3 years
was
100% and 95% in SABR group; 88% and 79%
in surgical group
Difference in OS
between the two groups was
statistically significant
This difference in OS is significant in STARS
alone but not in ROSEL alone
7 patients died:
6 in surgery group (2 PD, 1
secondary primary lung cancer, 1 surgical
adverse event, 2 comorbidities) and 1 in SABR
group (PD)